My work focuses on clinical pharmacology, toxicology, and occupational health, with studies on the bioavailability, bioequivalence, and safety of various pharmaceuticals. I am also interested in smoking cessation therapies, nicotine’s neuropharmacology, and the health impact of occupational exposures (e.g., aluminum, silica). My goal is to support safer, evidence-based therapies at the intersection of pharmacology and public health.